Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kriegsmann

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Analytical and Bioanalytical Chemistry|May 4, 2015
Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid depositsRita Casadonte, Mark Kriegsmann, Sören-Oliver Deininger, et al.
Pathology, Research and Practice|March 1, 2018
Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutationsMark Kriegsmann, Alexander Harms, Daniel Kazdal, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2022
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offsFabian Stögbauer, Manuela Lautizi, Mark Kriegsmann, et al.
Proteomics. Clinical Applications|September 15, 2018
In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak IntensityRémi Longuespée, Katharina Kriegsmann, Martin Cremer, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent PrognosisKatharina Kriegsmann, Julia S Klee, Manfred Hensel, et al.
Experimental and Molecular Pathology|June 27, 2015
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancerMelanie Maierthaler, Mark Kriegsmann, Cike Peng, et al.
Cancers|December 23, 2022
Multimodal Lung Cancer Subtyping Using Deep Learning Neural Networks on Whole Slide Tissue Images and MALDI MSICharlotte Janßen, Tobias Boskamp, Jean Le'Clerc Arrastia, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Analytical and Bioanalytical Chemistry|May 4, 2015
Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid depositsRita Casadonte, Mark Kriegsmann, Sören-Oliver Deininger, et al.
Pathology, Research and Practice|March 1, 2018
Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutationsMark Kriegsmann, Alexander Harms, Daniel Kazdal, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2022
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offsFabian Stögbauer, Manuela Lautizi, Mark Kriegsmann, et al.
Proteomics. Clinical Applications|September 15, 2018
In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak IntensityRémi Longuespée, Katharina Kriegsmann, Martin Cremer, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent PrognosisKatharina Kriegsmann, Julia S Klee, Manfred Hensel, et al.
Experimental and Molecular Pathology|June 27, 2015
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancerMelanie Maierthaler, Mark Kriegsmann, Cike Peng, et al.
Cancers|December 23, 2022
Multimodal Lung Cancer Subtyping Using Deep Learning Neural Networks on Whole Slide Tissue Images and MALDI MSICharlotte Janßen, Tobias Boskamp, Jean Le'Clerc Arrastia, et al.
Pageof 18